Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Sciatica Treatment Market

Sciatica Treatment Market Share

  • Report ID: GMI8504
  • Published Date: Mar 2024
  • Report Format: PDF

Sciatica Treatment Market Share

The sciatica treatment industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.
 

Sciatica Treatment Market Companies

Some of the eminent market participants operating in the sciatica treatment industry include:

  • Abbott Laboratories
  • Amneal Pharmaceuticals LLC.
  • Bayer AG
  • Bristol Myers Squibb
  • Eliem Therapeutics
  • Novartis AG
  • Pfizer Inc.
  • Scilex Holding
  • Sinfonia Biotherapeutics
  • Sorrento Therapeutics
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global sciatica treatment industry was valued at around USD 4.8 billion in 2023 and is expected to reach around USD 10 billion by 2032, driven by the increasing prevalence of sciatica, coupled with growing awareness related to available treatments.

The nonsteroidal anti-inflammatory drugs (NSAIDs) segment was valued at USD 2 billion in 2023 and will continue to gain traction through 2032, as they are more cost-effective, and are known for their effectiveness in reducing pain and inflammation.

North America sciatica treatment market accounted for USD 2 billion in 2023, favored by healthcare education initiatives targeting both healthcare professionals and the public.

Abbott Laboratories, Amneal Pharmaceuticals LLC., Bayer AG, Bristol Myers Squibb, Eliem Therapeutics, Novartis AG, Pfizer Inc., Scilex Holding, Sinfonia Biotherapeutics, and Sorrento Therapeutics.

Sciatica Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 194
  • Countries covered: 22
  • Pages: 110
 Download Free Sample